Breaking News Instant updates and real-time market news.

LPSN

LivePerson

$11.60

0.25 (2.20%)

, AAPL

Apple

$146.34

4.07 (2.86%)

08:14
06/20/17
06/20
08:14
06/20/17
08:14

LivePerson price target raised to $15 from $10 at Roth Capital

Roth Capital analyst Richard Baldry noted that LivePerson (LPSN) has announced partnering efforts around corporate messaging with both Apple (AAPL) and IBM (IBM) in the past week, which he points to as evidence that the enterprise messaging sector appears to be gaining momentum and mainstream acceptance. Baldry, who believes momentum in LivePerson's messaging segment is likely to accelerate in 2H17, raised his price target on the stock to $15 from $10 and keeps a Buy rating on the shares.

LPSN

LivePerson

$11.60

0.25 (2.20%)

AAPL

Apple

$146.34

4.07 (2.86%)

IBM

IBM

$154.84

-0.54 (-0.35%)

LPSN LivePerson
$11.60

0.25 (2.20%)

07/07/16
BNCH
07/07/16
UPGRADE
Target $9
BNCH
Buy
LivePerson upgraded to Buy from Hold at Benchmark
10/19/16
ROTH
10/19/16
NO CHANGE
Target $10
ROTH
Buy
LivePerson new market opportunity emerging, says Roth Capital
Roth Capital analyst Richard Baldry notes that LivePerson (LPSN) has announced support for a new Google (GOOGL; GOOG) AdWords technology extension that enables consumers to message companies directly from "pay-per-click" ads, which he views as a positive incremental growth opportunity. Given this is a dominant form of mass-market digital advertising, the analyst believes this should open up new growth opportunities in 2017 as recognition of its availability grows. Baldry reiterates a Buy rating and $10 price target on LivePerson's shares.
05/11/17
CHLM
05/11/17
UPGRADE
CHLM
Buy
LivePerson upgraded to Buy from Hold at Craig-Hallum
AAPL Apple
$146.34

4.07 (2.86%)

06/15/17
UBSW
06/15/17
NO CHANGE
Target $35
UBSW
Buy
Jabil Circuit price target raised to $35 from $30 at UBS
UBS analyst Steven Milunovich raised his price target on Jabil Circuit (JBL) to $35 from $30 following solid Q3 results and its positive 2018 outlook. The analyst said the company still has a 24% revenue dependence on Apple (AAPL). Based on its guidance for 2018, it must have reasonable confidence in the iPhone 8 cycle, said Milunovich, who reiterated his Buy rating on Jabil shares.
06/15/17
SBSH
06/15/17
NO CHANGE
Target $163
SBSH
Buy
Citi on Apple buying athenahealth? 'Never say never'
After CNBC reported that Apple (AAPL) is working on making the iPhone into a centralized management of patient health data, Citi analyst Garen Sarafian says athenahealth (ATHN) is a "well-suited candidate" to help. In a research note titled "Apple For athenahealth? Never Say Never," the analyst argues that athenahealth would accelerate Apple's efforts for interoperability. He believes Apple "would be one of few homes" that CEO Jonathan Bush would consider. Sarafian has a Buy rating on athenahealth with a $163 price target. The digital provider of medical records is down 42c to $142.34 in midday trading.
06/16/17
MSCO
06/16/17
NO CHANGE
Target $177
MSCO
Overweight
Recent Apple pullback largely due to overall tech weakness, says Morgan Stanley
Morgan Stanley analyst Katy Huberty believes the recent pullback in Apple shares, which are down 7% in the last week, is largely a result of overall weakness in the tech sector and not a change in investor sentiment towards the stock. She notes that Apple shares have risen an average of 18% in the 3 months prior to iPhone announcements over the last ten years, which she believes suggests the recent weakness creates an attractive opportunity to buy the stock. Huberyty keeps an Overweight rating and $177 price target on Apple.
06/19/17
MAXM
06/19/17
NO CHANGE
Target $180
MAXM
Buy
Apple price target raised to $180 after international survey at Maxim
Maxim analyst Nehal Chokshi raised his price target on Apple to $180 from $171 after the firm's May survey pointed to significant pent-up demand from new and existing iPhone users in China. Choksi raised his FY18 revenue and earnings estimates for Apple after increasing his iPhone unit forecast by 19% and his average selling price view by 4%. He keeps a Buy rating on Apple shares.
IBM IBM
$154.84

-0.54 (-0.35%)

06/08/17
STFL
06/08/17
NO CHANGE
STFL
IBM defended after CNBC report at Stifel
After CNBC reported that Facebook's (FB) WhatsApp had decided to stop using IBM's (IBM) cloud service and build its own solution, Stifel analyst David Grossman says that WhatsApp accounted for a tiny portion of IBM's cloud/outsourcing revenue. The analyst reiterated that bookings disclosed by IBM so far this quarter increase his confidence that its Infrastructure Services business "can stabilize in 2H17, all else being equal." He notes that the business accounts for about 30% of the company's revenue. Devitt keeps a $182 price target and Buy rating on the stock.
05/23/17
MAXM
05/23/17
NO CHANGE
Target $41
MAXM
Buy
Nutanix pact with IBM potentially more powerful than Dell deal, says Maxim
Maxim analyst Nehal Chokshi said he views Nutanix' (NTNX) announcement of a multi-year initiative that will combine IBM's (IBM) P-series servers and Nutanix' Enterprise Cloud Platform as a "very significant mid-term positive." He believes the partnership gives IBM a powerful infrastructure software answer to VMware (VMW) and Microsoft (MSFT) and sees the relationship with the potential to be even more powerful than the Dell relationship that powered Nutanix' improving FY16 sales productivity and cash flow. Chokshi keeps a Buy rating on Nutanix but trimmed his price target to $41 from $42 to account for Dell siphoning Nutanix leads to VMware, as previously discussed.
05/19/17
05/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Bernstein initiated Nvidia (NVDA) with an Outperform and a $165 price target. 2. Cantor Fitzgerald initiated Thermo Fisher (TMO) with an Overweight rating and $194 price target. 3. Pacific Crest initiated IBM (IBM) with a Sector Weight rating. 4. Conduent (CNDT) initiated with a Market Perform rating and $18 price target at Cowen. 5. JMP Securities started coverage of Spring Bank Pharmaceuticals (SBPH) with a $20 price target and an Outperform rating. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/18/17
05/18/17
INITIATION

Sector Weight
IBM initiated with a Sector Weight at Pacific Crest

TODAY'S FREE FLY STORIES

SPX

S&P 500

, SPY

SPDR S&P 500 ETF Trust

$279.60

0.46 (0.16%)

12:36
01/19/18
01/19
12:36
01/19/18
12:36
Periodicals
Trump seeks meeting with Schumer to avert shutdown, NY Times reports »

Maggie Haberman of the…

SPX

S&P 500

SPY

SPDR S&P 500 ETF Trust

$279.60

0.46 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

12:31
01/19/18
01/19
12:31
01/19/18
12:31
Hot Stocks
Breaking Hot Stocks news story on NuCana »

NuCana resumes, up 43% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.49

0.35 (0.13%)

, IEMG

iShares Core MSCI Emerging Markets

$60.61

0.305 (0.51%)

12:30
01/19/18
01/19
12:30
01/19/18
12:30
Technical Analysis
On The Fly: ETF fund flow highlights »

Flows continued to be…

SPY

SPDR S&P 500 ETF Trust

$279.49

0.35 (0.13%)

IEMG

iShares Core MSCI Emerging Markets

$60.61

0.305 (0.51%)

IEFA

iShares Core MSCI EAFE ETF

$69.52

0.215 (0.31%)

EWJ

iShares MSCI Japan Index Fund

$63.74

0.31 (0.49%)

BNDX

Vanguard Total International Bond ETF

$54.18

-0.02 (-0.04%)

EEM

MSCI Emerging Markets Index

$50.31

0.2775 (0.55%)

IWM

iShares Trust Russell 2000 Index Fund

$157.91

1.37 (0.88%)

GLD

SPDR Gold Trust

$126.65

0.79 (0.63%)

SVXY

ProShares Short VIX Short-Term Futures

$131.85

-0.45 (-0.34%)

IWD

iShares Russell 1000 Value

$128.57

0.09 (0.07%)

JNK

SPDR Barclays High Yield Bond

$36.80

-0.015 (-0.04%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$119.83

-0.315 (-0.26%)

IEF

iShares 7-10 Year Treasury Bond ETF

$104.06

-0.33 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

12:30
01/19/18
01/19
12:30
01/19/18
12:30
Hot Stocks
Breaking Hot Stocks news story on NuCana »

NuCana PLC (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$162.44

-6.68 (-3.95%)

, AXP

American Express

$97.11

-2.75 (-2.75%)

12:29
01/19/18
01/19
12:29
01/19/18
12:29
General news
On The Fly: Top stock stories at midday »

Stocks opened with minor…

IBM

IBM

$162.44

-6.68 (-3.95%)

AXP

American Express

$97.11

-2.75 (-2.75%)

GE

General Electric

$16.35

-0.425 (-2.53%)

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

BIIB

Biogen

$344.44

-0.43 (-0.12%)

NKE

Nike

$66.64

2.525 (3.94%)

IPHI

Inphi

$33.39

-2.01 (-5.68%)

MKC

McCormick

$98.72

-4.19 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 07

    Feb

  • 08

    Mar

EA

Electronic Arts

$115.28

2.14 (1.89%)

, ATVI

Activision Blizzard

$69.80

-0.56 (-0.80%)

12:28
01/19/18
01/19
12:28
01/19/18
12:28
Hot Stocks
EA in focus after NPD says 'Battlefront II' second-best selling game in December »

Shares of Electronic Arts…

EA

Electronic Arts

$115.28

2.14 (1.89%)

ATVI

Activision Blizzard

$69.80

-0.56 (-0.80%)

TTWO

Take-Two

$117.27

1.18 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 30

    Jan

  • 08

    Feb

  • 21

    Feb

  • 22

    Feb

  • 07

    Dec

12:25
01/19/18
01/19
12:25
01/19/18
12:25
General news
Treasury's $25 M 6-day CMB stopped at 1.210% »

Treasury's $25 M…

BHGE

Baker Hughes

$34.63

-0.11 (-0.32%)

12:20
01/19/18
01/19
12:20
01/19/18
12:20
Options
Put buying in Baker Hughes ahead of earnings »

Put buying in Baker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.70

0.55 (3.63%)

12:19
01/19/18
01/19
12:19
01/19/18
12:19
Hot Stocks
Breaking Hot Stocks news story on Momenta 

Momenta trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
01/19/18
01/19
12:17
01/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASFI

Asta Funding

$7.35

0.05 (0.68%)

12:16
01/19/18
01/19
12:16
01/19/18
12:16
Hot Stocks
Asta Funding receives Nasdaq non-compliance letter »

Asta Funding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

12:16
01/19/18
01/19
12:16
01/19/18
12:16
Hot Stocks
NuCana to resume trading at 12:30 pm ET »

NuCana is scheduled to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
01/19/18
01/19
12:16
01/19/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.15

-0.35 (-2.26%)

12:15
01/19/18
01/19
12:15
01/19/18
12:15
Hot Stocks
Breaking Hot Stocks news story on Momenta »

Momenta jumps 14%, halted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$14.27

0.18 (1.28%)

12:15
01/19/18
01/19
12:15
01/19/18
12:15
Options
MiMedx put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.15

-0.35 (-2.26%)

12:14
01/19/18
01/19
12:14
01/19/18
12:14
Periodicals
Breaking Periodicals news story on Momenta »

Momenta weighing options,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$15.15

-0.35 (-2.26%)

12:14
01/19/18
01/19
12:14
01/19/18
12:14
Hot Stocks
Breaking Hot Stocks news story on Momenta »

Momenta trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRG

NRG Energy

$26.50

-0.31 (-1.16%)

12:05
01/19/18
01/19
12:05
01/19/18
12:05
Options
NRG Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMNB

American National Bankshares

$39.10

-0.8 (-2.01%)

12:03
01/19/18
01/19
12:03
01/19/18
12:03
Hot Stocks
American National Bankshares announces 300,000 share repurchase program »

American National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBIB

Porter Bancorp

$13.76

0.06 (0.44%)

12:02
01/19/18
01/19
12:02
01/19/18
12:02
Hot Stocks
PBI Bank changes name to Limestone Bank »

In the first weeks of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

12:01
01/19/18
01/19
12:01
01/19/18
12:01
Hot Stocks
NuCana reports 'promising' clinical data on Acelarin »

NuCana announced interim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCNA

NuCana

$14.49

1.28 (9.69%)

11:55
01/19/18
01/19
11:55
01/19/18
11:55
Hot Stocks
Breaking Hot Stocks news story on NuCana »

NuCana PLC (ADS) trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$46.51

-0.27 (-0.58%)

11:55
01/19/18
01/19
11:55
01/19/18
11:55
Options
Mylan put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 08

    Mar

BTC

Bitcoin

, BAC

Bank of America

$31.55

0.07 (0.22%)

11:52
01/19/18
01/19
11:52
01/19/18
11:52
Hot Stocks
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

BAC

Bank of America

$31.55

0.07 (0.22%)

MS

Morgan Stanley

$56.67

0.83 (1.49%)

GS

Goldman Sachs

$252.15

1.18 (0.47%)

V

Visa

$122.10

-1.015 (-0.82%)

AMD

AMD

$12.47

0.29 (2.38%)

NVDA

Nvidia

$224.44

-0.28 (-0.12%)

OSTK

Overstock.com

$71.25

-4.4 (-5.82%)

DPW

DPW Holdings

$2.30

-0.05 (-2.13%)

LBCC

Long Blockchain Corp.

$4.51

0.3 (7.13%)

KODK

Kodak

$10.05

-0.1 (-0.99%)

SSC

Seven Stars Cloud Group

$4.53

-0.1 (-2.16%)

RIOT

Riot Blockchain

$19.80

2.04 (11.49%)

LFIN

Longfin

$44.69

6.09 (15.78%)

TEUM

Pareteum

$2.37

0.01 (0.42%)

SRAX

Social Reality

$4.96

0.17 (3.55%)

GBTC

Bitcoin Investment Trust

$1,857.00

221 (13.51%)

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 30

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 15

    Feb

AOS

A.O. Smith

$66.32

0.41 (0.62%)

11:51
01/19/18
01/19
11:51
01/19/18
11:51
Hot Stocks
A.O. Smith announces 29% boost in dividend »

Directors of A. O. Smith…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.